Ewopharma - About the company
Ewopharma is an unfunded company based in Schaffhausen (Switzerland), founded in 1959. It operates as a Provider of business consulting services for pharmaceutical companies. Ewopharma has not raised any funding yet. The company has 352 active competitors, including 1 funded and 16 that have exited. Its top competitors include companies like Axmed, Adelphi Group and Best Practices.
Key Metrics
Founded Year
1959
Location
Schaffhausen, Switzerland
Stage
Unfunded
Ranked
3rd among 352 active competitors
Employee Count
394 as on Sep 30, 2026
Legal entities associated with Ewopharma
Ewopharma is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Ewopharma AG CIN: 310101 , Switzerland, Active | Dec 08, 2022 | - | - | - |
Ewopharma CIN: 40203361746 , Latvia, Active | Nov 23, 2021 | €0 - €1M (As on Dec 31, 2024) | 2 (As on Dec 31, 2023) | - |
EWOPHARMA D.O.O. CIN: 4875964539 , Croatia, Active | Oct 14, 2008 | €1M - €10M (As on Dec 31, 2024) | - |
Sign up to download Ewopharma's company profile
Ewopharma's funding and investors
Ewopharma has not raised any funding rounds yet.
Ewopharma's founders and board of directors
Founder? Claim ProfileEwopharma's employee count trend
Ewopharma has 394 employees as of Sep 26. Here is Ewopharma's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Ewopharma's Competitors and alternates
Top competitors of Ewopharma include Axmed, Adelphi Group and Best Practices. Here is the list of Top 10 competitors of Ewopharma, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Axmed 2023, Basel (Switzerland), Seed | Platform connecting healthcare providers with prequalified medicine manufacturers in low- and middle-income countries | $2M | 52/100 | |
2nd | Adelphi Group 1986, Bollington (United Kingdom), Acquired | Provider of biopharma business consulting services | - | - | 47/100 |
3rd | Ewopharma 1959, Schaffhausen (Switzerland), Unfunded | Provider of business consulting services for pharmaceutical companies | - | - | 44/100 |
4th | Best Practices 1992, Chapel Hill (United States), Unfunded | Provider of financial, healthcare, and manufacturing consulting services | - | - | 37/100 |
5th | Bioscience Advisors 2011, Walnut Creek (United States), Acquired | Provider of consulting services for biopharma sector | - | - | 34/100 |
6th | CellSource 2015, Shibuya (Japan), Public | Provider of biopharma business consulting services | - | - | 31/100 |
7th | D Cube Analytics 2014, Bengaluru (India), Acquired | Analytics Platform for Pharmaceutical Brand Management | - | - | 30/100 |
8th | Venture Valuation 1999, Zurich (Switzerland), Unfunded | Provider of valuation, partner search, and business development support services | - | - | 29/100 |
9th | ProcDNA 2020, San Francisco (United States), Unfunded | Provider of software development services for pharmaceutical industry | - | - | 29/100 |
10th | Pharmaceutical company specializing in the distribution of dry eye relief and business development solutions | - | - | 28/100 |
Looking for more details on Ewopharma's competitors? Click here to see the top ones
Ewopharma's Investments and acquisitions
Ewopharma has made no investments or acquisitions yet.
Reports related to Ewopharma
Here is the latest report on Ewopharma's sector:
News related to Ewopharma
Media has covered Ewopharma for 1 event in last 1 year, It was about partnerships.
•
•
CStone Pharmaceuticals’ Collaboration Agreement with EwopharmaGlobal Legal Chronicle•Jun 20, 2024•CStone Pharma, Ewopharma
•
•
Can-Fite Expands the Out-Licensing Deal with Ewopharma to Include the Pancreatic Cancer IndicationBusiness Wire•Jan 30, 2024•Can-Fite, Ewopharma
•
Ewopharma AG: Schaffhausen pharmaceutical company takes over NeomedShn•Jun 04, 2023•NEOMED, Ewopharma
•
Can-fite Signs $42.7 Million Out-licensing Deal With EwopharmaBusiness Wire•Mar 16, 2021•Can-Fite, Ewopharma
•
Ewopharma and Eisai Announce Commercial Partnership in Central Eastern Europe for Lenvima (Lenvatinib)CMOCRO•Mar 26, 2020•Ewopharma, Eisai
•
Ewopharma and Vianex Announce Collaboration to Distribute the Essential Antibiotic Amikacin in SwitzerlandCMOCRO•Jul 29, 2019•Ewopharma, Vianex
•
•
Ewopharma Release Company Partners With Biogen To Commercialise BENEPALI And FLIXABI In Central Eastern EuropeBioSpace•Jan 23, 2017•Ewopharma
Are you a Founder ?
FAQs about Ewopharma
Explore our recently published companies
- Christoph Hein - Lemwerder based, Unfunded company
- Sandra Godwin - Unfunded company
- KCG - Unfunded company
- Omnipresence Exim - Hyderabad based, 2019 founded, Unfunded company
- ValaCare - Toronto based, 2026 founded, Unfunded company
- AI Fairness 360 - Unfunded company
_1564988452781.png?format=webp&height=120&width=120)